Cargando…
Rivaroxaban in Acute Coronary Syndromes: We Have a Compass and an Atlas, But Where Are We Headed?
See Article by Gibson et al
Autores principales: | Harrison, Robert W., Newby, L. Kristin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474921/ https://www.ncbi.nlm.nih.gov/pubmed/30813822 http://dx.doi.org/10.1161/JAHA.119.012014 |
Ejemplares similares
-
Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023) -
Craniofacial genetics: Where have we been and where are we going?
por: Weinberg, Seth M., et al.
Publicado: (2018) -
Acute childhood leukemia in India: Where are we going, where have we been?
por: Kanwar, Vikramjit Singh
Publicado: (2016) -
Horizons of Psychiatric Genetics and Epigenetics: Where Are We and Where Are We Heading?
por: Mostafavi Abdolmaleky, Hamid
Publicado: (2014) -
Sequencing Technologies and Analyses: Where Have We Been and Where Are We Going?
por: Bansal, Vikas, et al.
Publicado: (2019)